NDC properties for "ticlopidine hydrochloride 250 MG Oral Tablet" (RxCUI 313406)
About this data
The tables show NDC propoerties for ticlopidine hydrochloride 250 MG Oral Tablet with the RxCUI 313406
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for ticlopidine hydrochloride 250 MG Oral Tablet (RxCUI 313406)
| ANDA | ANDA075149 |
|---|---|
| MMSL_CODE | BD3322 |
| MMSL_CODE | CD3322 |
| RxCUI | 313406 |
| SNOMEDCT | 319801001 |
| SPL_SET_ID | 77d619f8-05a3-408a-a6f8-1511694b6a24 |
| VUID | 4010128 |
| Prescribable Synonym | ticlopidine HCl 250 MG Oral Tablet |
| RXNAV_STR | ticlopidine hydrochloride 250 MG Oral Tablet |
| RxNorm Name | ticlopidine hydrochloride 250 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 313406) |
NDC Properties
NDC Item 57664032706
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-06 |
| NDC Item | 57664032706 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-06) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032713
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-13 |
| NDC Item | 57664032713 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (57664-327-13) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032783
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-83 |
| NDC Item | 57664032783 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (57664-327-83) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032786
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-86 |
| NDC Item | 57664032786 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-86) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 60505002702
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-2 |
| NDC Item | 60505002702 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (60505-0027-2) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002704
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-4 |
| NDC Item | 60505002704 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (60505-0027-4) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002707
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-7 |
| NDC Item | 60505002707 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (60505-0027-7) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 57664032706
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-06 |
| NDC Item | 57664032706 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-06) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032713
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-13 |
| NDC Item | 57664032713 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (57664-327-13) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032783
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-83 |
| NDC Item | 57664032783 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (57664-327-83) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032786
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-86 |
| NDC Item | 57664032786 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-86) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 60505002702
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-2 |
| NDC Item | 60505002702 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (60505-0027-2) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002704
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-4 |
| NDC Item | 60505002704 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (60505-0027-4) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002707
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-7 |
| NDC Item | 60505002707 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (60505-0027-7) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 57664032706
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-06 |
| NDC Item | 57664032706 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-06) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032713
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-13 |
| NDC Item | 57664032713 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (57664-327-13) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032783
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-83 |
| NDC Item | 57664032783 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (57664-327-83) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032786
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-86 |
| NDC Item | 57664032786 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-86) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 60505002702
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-2 |
| NDC Item | 60505002702 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (60505-0027-2) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002704
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-4 |
| NDC Item | 60505002704 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (60505-0027-4) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002707
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-7 |
| NDC Item | 60505002707 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (60505-0027-7) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 57664032706
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-06 |
| NDC Item | 57664032706 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-06) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032713
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-13 |
| NDC Item | 57664032713 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (57664-327-13) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032783
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-83 |
| NDC Item | 57664032783 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (57664-327-83) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032786
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-86 |
| NDC Item | 57664032786 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-86) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 60505002702
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-2 |
| NDC Item | 60505002702 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (60505-0027-2) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002704
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-4 |
| NDC Item | 60505002704 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (60505-0027-4) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002707
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-7 |
| NDC Item | 60505002707 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (60505-0027-7) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 57664032706
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-06 |
| NDC Item | 57664032706 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-06) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032713
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-13 |
| NDC Item | 57664032713 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (57664-327-13) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032783
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-83 |
| NDC Item | 57664032783 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (57664-327-83) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032786
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-86 |
| NDC Item | 57664032786 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-86) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 60505002702
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-2 |
| NDC Item | 60505002702 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (60505-0027-2) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002704
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-4 |
| NDC Item | 60505002704 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (60505-0027-4) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002707
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-7 |
| NDC Item | 60505002707 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (60505-0027-7) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 57664032706
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-06 |
| NDC Item | 57664032706 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-06) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032713
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-13 |
| NDC Item | 57664032713 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (57664-327-13) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032783
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-83 |
| NDC Item | 57664032783 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (57664-327-83) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032786
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-86 |
| NDC Item | 57664032786 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-86) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 60505002702
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-2 |
| NDC Item | 60505002702 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (60505-0027-2) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002704
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-4 |
| NDC Item | 60505002704 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (60505-0027-4) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002707
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-7 |
| NDC Item | 60505002707 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (60505-0027-7) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 57664032706
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-06 |
| NDC Item | 57664032706 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-06) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032713
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-13 |
| NDC Item | 57664032713 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (57664-327-13) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032783
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-83 |
| NDC Item | 57664032783 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (57664-327-83) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 57664032786
| NDC 9 | 57664-327 |
|---|---|
| NDC 10 | 57664-327-86 |
| NDC Item | 57664032786 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-86) |
| ANDA | ANDA075526 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 97406 |
| Imprint code | 327 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2016-05-31 |
| Marketing effective time low | 2002-09-26 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 15 mm |
| Related queries | Properties for NDC 9 57664-327 |
NDC Item 60505002702
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-2 |
| NDC Item | 60505002702 |
| Packaging | 30 TABLET, FILM COATED in 1 BOTTLE (60505-0027-2) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002704
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-4 |
| NDC Item | 60505002704 |
| Packaging | 60 TABLET, FILM COATED in 1 BOTTLE (60505-0027-4) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |
NDC Item 60505002707
| NDC 9 | 60505-0027 |
|---|---|
| NDC 10 | 60505-0027-7 |
| NDC Item | 60505002707 |
| Packaging | 500 TABLET, FILM COATED in 1 BOTTLE (60505-0027-7) |
| ANDA | ANDA075089 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 266137 |
| Imprint code | APO;027 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-04-30 |
| Marketing effective time low | 1999-07-01 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48345 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-0027 |